Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA

[1]  P. Febbo,et al.  A polymorphism of the 5 alpha-reductase gene and its association with prostate cancer: a case-control analysis. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[2]  D M Parkin,et al.  Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. , 1997, European journal of cancer.

[3]  M. Pike,et al.  5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males , 1992, The Lancet.

[4]  D. Russell,et al.  Natural mutagenesis study of the human steroid 5α-reductase 2 isozyme , 1994 .

[5]  M. Pike,et al.  Endogenous hormones as a major factor in human cancer. , 1982, Cancer research.

[6]  M. Pike,et al.  Genetic variability of the human SRD5A2 gene: implications for prostate cancer risk. , 1995, Cancer research.

[7]  E. Lander,et al.  Androgen Metabolism and Prostate Cancer: Establishing a Model of Genetic Susceptibility , 1998, European Urology.

[8]  T. Beaty,et al.  Mendelian inheritance of familial prostate cancer. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Montie Je.  1992 staging system for prostate cancer , 1993 .

[10]  D. Russell,et al.  Unusual length polymorphism in human steroid 5α-reductase type 2 gene (SRD5A2) , 1993 .

[11]  F. Collins,et al.  Evidence for a prostate cancer susceptibility locus on the X chromosome. , 1998, Nature Genetics.

[12]  Taylor Murray,et al.  Cancer statistics, 1998 , 1998, CA: a cancer journal for clinicians.

[13]  M. Pike,et al.  A prevalent missense substitution that modulates activity of prostatic steroid 5alpha-reductase. , 1997, Cancer research.

[14]  N. Vogelzang.  Comprehensive Textbook of Genitourinary Oncology , 1996 .

[15]  C. Huggins,et al.  Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate , 1941, CA: a cancer journal for clinicians.

[16]  W. Catalona,et al.  The diagnosis and treatment of prostate cancer. , 1991, Annual review of medicine.

[17]  E. Goode,et al.  Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25. , 1997, American journal of human genetics.

[18]  D A Meyers,et al.  Major Susceptibility Locus for Prostate Cancer on Chromosome 1 Suggested by a Genome-Wide Search , 1996, Science.

[19]  U. Francke,et al.  Molecular genetics of steroid 5 alpha-reductase 2 deficiency. , 1992, The Journal of clinical investigation.

[20]  E. Stoner.  5α‐reductase inhibitors/finasteride , 1996 .

[21]  W. Vogel,et al.  Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. , 1998, American journal of human genetics.

[22]  D O Stram,et al.  A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. , 2000, American journal of epidemiology.

[23]  O S Miettinen,et al.  Proportion of disease caused or prevented by a given exposure, trait or intervention. , 1974, American journal of epidemiology.